Overview

Effect of Age on the Renal Clearance of Adefovir

Status:
Withdrawn
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Healthy African American subjects with normal hepatic and renal function will be administered 10mg adefovir dipivoxil in a fasting state. Subjects will have blood and urine collections over the following 24 hours for the measurement of adefovir renal clearance. To investigate the role of age in renal adefovir elimination, 8 subjects will be enrolled from each of the following age groups: 18-25 years and 48-55 years.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Adefovir
Adefovir dipivoxil